Previous Close | 43.75 |
1-Year Change | 78.43% |
6-Months Change | 100.5% |
3-Months Change | 19.57% |
Moving Avg (50d) | 42.359 |
Moving Avg (200d) | 31.156 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.19B |
Beta (3-Years) | 2.13 |
Revenue Growth (ttm) | 21.01% |
Net Profit Margin (ttm) | -14.56% |
Return On Assets (ttm) | -4.44% |
EPS (ttm) | -0.69 |
PE Ratio (ttm) | -63.41 |
Dividend Yield | % |
Asset Description: | Veracyte, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-04 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
44.625 | 45.938 | 46.813 | 48.125 | 50.313 | 52.5 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.